GlassScriptPhysician profile
John C Krebs
NPI 1972066355
$18,523.25
in general payments reported to CMS, 2019-2025
14 companies · $6,578 in 2025
The $6,578 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2020: $1,627 · 2021: $1,356 · 2022: $3,093 · 2023: $248 · 2024: $4,297 · 2025: $6,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $3,282 · Food and Beverage: $2,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $3,281.88 |
| Food and Beverage | $2,840.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $5,423.51 | 2019-2023 | |
| Smith+Nephew, INC. | $5,165.22 | 2024-2025 | |
| Stryker Corporation | $2,961.07 | 2022-2025 | Mako, Gamma, Insignia |
| Zimmer Biomet Holdings, INC. | $1,691.20 | 2024-2025 | Comprehensive Shoulder System, Identity, Genex |
| Medical Device Business Services, INC. | $1,349.23 | 2025 | Inhance |
| Arthrex, INC. | $1,230.56 | 2025 | |
| Depuy Synthes Sales INC. | $160.39 | 2025 | Na, Dynacord, Inhance |
| Becton, Dickinson and Company | $142.94 | 2024 | Arista Ah Flexitip |
| Si-Bone, INC. | $134.86 | 2021 | |
| Davol INC. | $116.16 | 2022 | |
| Nexus Medical Technologies LLC | $76.12 | 2025 | |
| Illuminoss Medical, INC. | $37.52 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $20.99 | 2022 | |
| Lightbody Medical Technologies INC | $13.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Krebs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.